Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan

Science of the Total Environment

Volumn 407, Issue 8, 2009, Pages 2608-2614

  Huang, Ya Li ^a   Hsueh, Yu Mei ^a   Huang, Yung Kai ^a   Yip, Ping Keung ^b   Yang, Mo Hsiung ^c   Chen, Chien Jen ^d,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenate; Arsenite; Carotid atherosclerosis; Cumulative arsenic exposure; Dimethylarsinic acid; Monomethylarsonic acid

Indexed keywords

ARSENATE; ARSENITE; CAROTID ATHEROSCLEROSIS; CUMULATIVE ARSENIC EXPOSURE; DIMETHYLARSINIC ACID; MONOMETHYLARSONIC ACID;

ABSORPTION SPECTROSCOPY; ALKYLATION; ATOMIC ABSORPTION SPECTROMETRY; ATOMIC SPECTROSCOPY; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; METHYLATION; NONMETALS; POTABLE WATER; RISK PERCEPTION; ULTRASONIC IMAGING; ULTRASONOGRAPHY; VANADIUM; WATER SUPPLY; WATER WELLS;

ARSENIC;

ARSENATE; ARSENITE; DISEASE; HEALTH RISK; METHYLATION; OCCUPATIONAL EXPOSURE;

ADULT; ARSENIC; ARSENIC POISONING; ARSENICALS; ARSENITES; CACODYLIC ACID; CAROTID ARTERY DISEASES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; METHYLATION; MIDDLE AGED; RISK FACTORS; TAIWAN; WATER POLLUTANTS, CHEMICAL;

ASIA; EURASIA; FAR EAST; TAIWAN;

EID: 61449224481     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2008.12.061     Document Type: Article

References (57)

1. Ahsan H., Chen Y., Kibriya M.G., Slavkovich V., Parvez F., Jasmine F., Gamble M.V., and Graziano J.H. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16 (2007) 1270-1278
2. Aposhian H.V., Zakharyan R.A., Avram M.D., Sampayo-Reyes A., and Wollenberg M.L. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198 (2004) 327-335
3. Aposhian H.V., Aposhian M.M., Aposhian H.V., and Aposhian M.M. Arsenic toxicology: five questions. Chemical Research in Toxicology 19 (2006) 1-15
4. Brima E.I., Jenkins R.O., Lythgoe P.R., Gault A.G., Polya D.A., and Haris P.I. Effect of fasting on the pattern of urinary arsenic excretion. J Environ Monit 9 (2007) 98-103
5. Buchet J.P., Lauwerys R., and Roels H. Comparison of several methods for the determination of arsenic compounds in water and in urine. Their application for the study of arsenic metabolism and for the monitoring of workers exposed to arsenic. Int Arch Occup Environ Health 46 (1980) 11-29
6. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., and Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25 (1995) 53-60
7. Chen C.J., Chiou H.Y., Chiang M.H., Lin L.J., and Tai T.Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16 (1996) 504-510
8. Chen Y., Factor-Litvak P., Howe GR., Graziano J.H., Brandt-Rauf P., Parvez F., van Geen A., and Ahsan H. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 165 (2007) 541-552
9. Chiou H.Y., Hsueh Y.M., Hsieh L.L., Hsu L.I., Hsu Y.H., Hsieh F.I., Wei M.L., Chen H.C., Yang H.T., Leu L.C., Chu T.H., Chen-Wu C., Yang M.H., and Chen C.J. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386 (1997) 197-207
10. Chiou H.Y., Huang W.I., Su C.L., Chang S.F., Hsu Y.H., and Chen C.J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28 (1997) 1717-1723
11. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., and Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol 36 (2006) 99-133
12. Del Razo L.M., Styblo M., Cullen W.R., and Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174 (2001) 282-293
13. Francesconi K.A., and Kuehnelt D. Determination of arsenic species: a critical review of methods and applications, 2000-2003. Analyst 129 (2004) 373-395
14. Francesconi K.A., Tanggaar R., McKenzie C.J., Goessler W., Francesconi K.A., Tanggaar R., McKenzie C.J., and Goessler W. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clinical Chemistry 48 (2002) 92-101
15. Gamble M.V., Liu X., Ahsan H., Pilsner J.R., Ilievski V., Slavkovich V., Parvez F., Chen Y., Levy D., Factor-Litvak P., and Graziano J.H. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84 (2006) 1093-1101
16. Gebel T.W. Arsenic methylation is a process of detoxification through accelerated excretion. Int J Hyg Environ Health 205 (2002) 505-508
17. Gong Z.L., Lu X.F., Cullen W.R., and Le X.C. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom 16 (2001) 1409-1413
18. Hara A., Ohkubo T., Kikuya M., Shintani Y., Obara T., Metoki H., Inoue R., Asayama K., Hashimoto T., Harasawa T., Aono Y., Otani H., Tanaka K., Hashimoto J., Totsune K., Hoshi H., Satoh H., and Imai Y. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens 25 (2007) 321-327
19. Heck J.E., Gamble M.V., Chen Y., Graziano J.H., Slavkovich V., Parvez F., Baron J.A., Howe G.R., and Ahsan H. Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr 85 (2007) 1367-1374
20. Hsueh Y.M., Huang Y.L., Huang C.C., Wu W.L., Chen H.M., Yang M.H., Lue L.C., and Chen C.J. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A 54 (1998) 431-444
21. Hsueh Y.M., Hsu M.K., Chiou H.Y., Yang M.H., Huang C.C., and Chen C.J. Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. Toxicol Lett 133 (2002) 83-91
22. Hsueh Y.M., Ko Y.F., Huang Y.K., Chen H.W., Chiou H.Y., Huang Y.L., Yang M.H., and Chen C.J. Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption. Toxicol Lett 137 (2003) 49-63
23. Huang Y.K., Tseng C.H., Huang Y.L., Yang M.H., Chen C.J., and Hsueh Y.M. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol 218 (2007) 135-142
24. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172 (2001) 249-261
25. Kitchin K.T., and Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol Lett 137 (2003) 3-13
26. Kuo T.L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning (1964), Institute of Pathology, National Taiwan University, Taiwan 7-13
27. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., and Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 139 (1994) 484-492
28. Lindberg A.L., Kumar R., Goessler W., Thirumaran R., Gurzau E., Koppova K., Rudnai P., Leonardi G., Fletcher T., and Vahter M. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 115 (2007) 1081-1086
29. Ma M., and Le X.C. Effect of arsenosugar ingestion on urinary arsenic speciation. Clin Chem 44 (1998) 539-550
30. McCarty K.M., Chen Y.C., Quamruzzaman Q., Rahman M., Mahiuddin G., Hsueh Y.M., Su L., Smith T., Ryan L., and Christiani D.C. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect 115 (2007) 341-345
31. Nordstrom D.K. Public health. Worldwide occurrences of arsenic in ground water. Science 296 (2002) 2143-2145
32. Paul D.S., Harmon A.W., Devesa V., Thomas D.J., and Styblo M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115 (2007) 734-742
33. Pi J., Horiguchi S., Sun Y., Nikaido M., Shimojo N., Hayashi T., Yamauchi H., Itoh K., Yamamoto M., Sun G., Waalkes M.P., and Kumagai Y. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic Biol Med 35 (2003) 102-113
34. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T., Aikawa H., Hopenhayn-Rich C., and Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110 (2002) 331-336
35. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., Yang M.H., Chen C.J., and Hsueh Y.M. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 218 (2007) 99-106
36. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., and Aposhian H.V. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem Res Toxicol 15 (2002) 692-698
37. Raml R., Goessler W., Traar P., Ochi T., and Francesconi K.A. Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2′,3′-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-d-riboside. Chem Res Toxicol 18 (2005) 1444-1450
38. Schlawicke E.K., Broberg K., Concha G., Nermell B., Warholm M., and Vahter M. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect 115 (2007) 599-605
39. Shraim A., Sekaran N.C., Anuradha C.D., and Hirano S. Speciation of arsenic in tube-well water samples collected from West Bengal, India, by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Appl Organomet Chem 16 (2002) 202-209
40. Simeonova P.P., and Luster M.I. Arsenic and atherosclerosis. Toxicol Appl Pharmacol 198 (2004) 444-449
41. Steinmaus C., Carrigan K., Kalman D., Atallah R., Yuan Y., and Smith A.H. Dietary intake and arsenic methylation in a U.S. Population. Environ Health Perspect 113 (2005) 1153-1159
42. Steinmaus C., Moore L.E., Shipp M., Kalman D., Rey O.A., Biggs M.L., Hopenhayn C., Bates M.N., Zheng S., Wiencke J.K., and Smith A.H. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J Toxicol Environ Health A 70 (2007) 159-170
43. Styblo M., Drobna Z., Jaspers I., Lin S., and Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110 Suppl 5 (2002) 767-771
44. Sun G., Xu Y., Li X., Jin Y., Li B., and Sun X. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 115 (2007) 648-652
45. Taylor A.J., Zhu D., Sullenberger L.E., Lee H.J., Lee J.K., and Grace K.A. Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2. Vasc Health Risk Manag 3 (2007) 159-164
46. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176 (2001) 127-144
47. Thomas D.J., Waters S.B., and Styblo M. Elucidating the pathway for arsenic methylation. Toxicol Appl Pharmacol 198 (2004) 319-326
48. Tseng C.H. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25 (2007) 1-22
49. Tseng W.P. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 40 (1989) 547-558
50. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., and Hsueh Y.M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206 (2005) 299-308
51. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci Prog 82 Pt 1 (1999) 69-88
52. Wang C.H., Jeng J.S., Yip P.K., Chen C.L., Hsu L.I., Hsueh Y.M., Chiou H.Y., Wu M.M., and Chen C.J. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105 (2002) 1804-1809
53. Wang Y.H., Wu M.M., Hong C.T., Lien L.M., Hsieh Y.C., Tseng H.P., Chang S.F., Su C.L., Chiou H.Y., and Chen C.J. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 192 (2007) 305-312
54. Wu H.Y., Chen K.P., Tseng W.P., and Hsu C.L. Epidemiologic studies on Blackfoot disease: I. Prevalence and incidence of the disease by age, sex, occupation and geographical distribution. Mem College Med Natl Taiwan Univ 7 (1961) 33-50
55. Wu M.M., Chiou H.Y., Ho I.C., Chen C.J., and Lee T.C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 111 (2003) 1429-1438
56. Wu M.M., Chiou H.Y., Hsueh Y.M., Hong C.T., Su C.L., Chang S.F., Huang W.L., Wang H.T., Wang Y.H., Hsieh Y.C., and Chen C.J. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol Appl Pharmacol 216 (2006) 168-175
57. Yamauchi H., and Fowler B.A. Toxicity and metabolism of inorganic and methylated arsenicals. In: Nriagu J.O. (Ed). Arsenic in the environment, part 2: human health and ecosystem effects (1994), John Wiley and Sons, New York 33-43